Document Detail


Prenatal diagnosis of Sanfilippo A syndrome: experience in 35 pregnancies at risk and the use of a new fluorogenic substrate for the heparin sulphamidase assay.
MedLine Citation:
PMID:  8905897     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have investigated the use of a 4-methylumbelliferone (MU)-derived artificial substrate, MU-alpha-D-N-sulphoglucosaminide, for the sulphamidase assay in chorionic villi and amniotic fluid cells. In the new two-step enzyme assay, fluorescent MU is released by the successive action of endogenous sulphamidase and an added yeast enzyme preparation which hydrolyses the MU-alpha-glucosaminide intermediate. Optimal conditions for a sensitive, accurate, and convenient procedure for use in the prenatal diagnosis of Sanfilippo A syndrome are described. Previously, prenatal diagnosis of Sanfilippo A syndrome has been achieved by a radioactive sulphamidase assay in chorionic villi or in cultured amniocytes and by two-dimensional electrophoresis of glycosaminoglycans in amniotic fluid. Our experience using these methods in 35 pregnancies at risk is reported. The feasibility of the new fluorogenic assay was evaluated by retrospective testing of stored homogenates of chorionic villi and amniotic fluid cells from 22 pregnancies at risk. Unequivocal assignment of the fetal status in five affected pregnancies and 17 pregnancies with a normal outcome confirms the reliability of the new sulphamidase assay, which is in every respect more convenient than the conventional method using 35S-radiolabelled heparin.
Authors:
W J Kleijer; E A Karpova; G C Geilen; J L Keulemans; J G Huijmans; I V Tsvetkova; Voznyi YaV; O P van Diggelen
Related Documents :
11035337 - Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1)...
8796797 - Predictive value of amniotic fluid index for oligohydramnios in patients with prolonged...
7400917 - Immune complexes in the sera and amniotic fluids of human pregnancy.
10174297 - Prenatal determination of human platelet antigen type 4 by dna amplification of amnioti...
12553697 - Expression of proliferation and apoptotic markers in human placenta during pregnancy.
11451817 - Reliability and validity of chest radiograph surveillance programs.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  16     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  1996 Sep 
Date Detail:
Created Date:  1997-02-11     Completed Date:  1997-02-11     Revised Date:  2008-08-16    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  829-35     Citation Subset:  IM    
Affiliation:
Department of Clinical Genetics, University Hospital, Erasmus University, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amniocentesis / methods*
Chorionic Villi / enzymology*
Chorionic Villi Sampling
Female
Fetal Diseases / diagnosis*
Humans
Hydrolases / deficiency,  metabolism*
Mucopolysaccharidosis III / diagnosis*
Pregnancy
Pregnancy, High-Risk*
Reference Values
Substrate Specificity
Chemical
Reg. No./Substance:
EC 3.-/Hydrolases; EC 3.10.1.1/N-sulfoglucosamine sulfohydrolase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  First-trimester chromosome diagnosis by lavage of the uterine cavity.
Next Document:  Cytogenetic and age-dependent risk factors associated with uniparental disomy 15.